Articles by GI Oncology Now Editors
The trio pondered the evolving landscape of upper GI cancer treatments, particularly in localized and advanced stages.
The trio delved into the nuances of dosing strategies for TAS-102 and fruquintinib for colorectal cancer, offering insights.
The trio highlighted the evolution of genetic mutations in colon cancer, pointing to recent studies on NGS.
Dr. Eng first shared her expertise on the current approaches to treating colon cancer, focusing on the use of ctDNA.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.